FOXM1 and ovarian carcinoma: In addition, FOXM1 has previously been shown to promote platinum resistance in ovarian cancer (Zhang et al., 2014; Brückner et al., 2021), and we observed several chemoresistant recurrent HGSC patients that showed coordinate upregulation of FOXM1 and RHNO1 (Figure 8C).